In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Ab1-positive cell lines

Paul La Rosée, Kara Johnson, Amie S. Corbin, Eric P. Stoffregen, Erika M. Moseson, Stephanie Willis, Michael M. Mauro, Junia V. Melo, Michael W. Deininger, Brian J. Druker

Research output: Contribution to journal › Article › peer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Ab1-positive cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds